Innovations in future directions & emerging therapies in diabetes and endocrinology are revolutionizing the landscape of metabolic disease treatment. Research on pancreatic beta-cell regeneration, stem cell therapy, and gene editing holds potential for long-term diabetes remission. Immunomodulatory approaches aim to halt autoimmune destruction in type 1 diabetes, while artificial intelligence-driven precision medicine is refining treatment plans for type 2 diabetes. Advancements in hormonal therapies, including novel incretin-based drugs and dual-hormone insulin delivery systems, are improving glycemic control. The integration of digital health solutions, closed-loop insulin delivery, and non-invasive glucose monitoring is enhancing patient autonomy. With continuous exploration of new targets, the future of diabetes and endocrinology promises transformative solutions for personalized and preventive care.
F Buck Willis
Christian College of Medicine, Belize
Mahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab Emirates
Anil Harrison
Midwestern University, United States
Wan Rosli Wan Ishak
Universiti Sains Malaysia, MalaysiaMahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab EmiratesF Buck Willis
Christian College of Medicine, BelizeAnil Harrison
Midwestern University, United States
Sujith Rajan
NYU Long Island School of Medicine, United StatesWan Rosli Wan Ishak
Universiti Sains Malaysia, Malaysia
Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences